Summary: This case report describes a 52-year-old woman with familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with volanesorsen.
Summary: This article discusses volanesorsen in the treatment of familial chylomicronaemia syndrome (FCS), a rare disorder of lipid metabolism characterized by high levels of triglycerides (TGs).
Summary: This case report describes a 15-day-old baby diagnosed with type V hyperlipoproteinemia (high blood fats and protein; HLP) treated with cholestyramine (Questran sachet) powder.
Summary: This study evaluated the effectiveness of volanesorsen (triglyceride-reducing drug) treatment in patients with familial chylomicronemia syndrome (disrupts the normal breakdown of fats in the body, causing a large amount of fat to build up in the blood; FCS).